Supplements News and Research

RSS

Triglyceride-lowering medication may lower stroke risk in people with heart disease

Taking the triglyceride-lowering medication icosapent ethyl cut the risk of stroke by an additional 36% in people at increased risk of cardiovascular disease who already have their bad cholesterol levels under control using statin medications, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

11 Mar 2021

Probiotic supplements increase the diversity of intestinal bacteria in extremely preterm infants

Extremely preterm infants can suffer from a life-threatening inflammation of the gut. A new clinical study has shown that supplements of a lactic acid bacterium may have positive effects by increasing the diversity of intestinal bacteria in these infants.

11 Mar 2021

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.

11 Mar 2021

Study describes the infection of human cells by intestinal pathogen during spaceflight

Astronauts face many challenges to their health, due to the exceptional conditions of spaceflight. Among these are a variety of infectious microbes that can attack their suppressed immune systems.

9 Mar 2021

A sneak peek of the current state and future use of artificial intelligence in pathology

Artificial intelligence can already scan images of the eye to assess patients for diabetic retinopathy, a leading cause of vision loss, and find evidence of strokes on brain CT scans.

8 Mar 2021

Despite modest progress, maternal and child undernutrition remains a key health concern

The Lancet today published the latest Series on Maternal and Child Undernutrition Progress, including three new papers that build upon findings from the previous 2008 and 2013 Series, which established an evidence-based global agenda for tackling undernutrition over the past decade.

8 Mar 2021

FDA authorizes first molecular non-prescription, at-home COVID-19 test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Cue COVID-19 Test for Home and Over The Counter (OTC) Use.

5 Mar 2021

FDA issues emergency use authorization for T-Detect COVID Test

Today, the U.S. Food and Drug Administration issued an emergency use authorization for the T-Detect COVID Test developed by Adaptive Biotechnologies.

5 Mar 2021

FDA plans to further reduce toxic elements in foods for babies and young children

The U.S. Food and Drug Administration takes exposure to toxic elements, such as arsenic, mercury, cadmium and lead, in the food supply extremely seriously, especially when it comes to protecting the health and safety of the youngest and most vulnerable in the population.

5 Mar 2021

Study: Grandmothers can play a key role in newborn care

Grandmothers can play a critical role in the care of newborn babies but are often excluded from national and international policies on neonatal care, says a new analysis.

5 Mar 2021

FDA alerts consumers about improper use of thermal imaging systems, warns firms for marketing unapproved devices

The U.S. Food and Drug Administration today alerted consumers, health care providers and other users of thermal imaging systems intended to measure human body temperature—also known as telethermographic systems, infrared thermographs, thermal cameras, and "fever cameras"—that improper use of the systems may provide inaccurate temperature readings due to a variety of factors.

5 Mar 2021

Federal court order requires New York-based dietary supplement manufacturer to cease operations

A dietary supplement manufacturer and two of its executives have been ordered by a federal court to stop manufacturing, holding, or distributing any articles of food, including dietary supplements, until they come into compliance with federal dietary supplement current good manufacturing practice regulations and other Federal Food, Drug, and Cosmetic Act (FD&C Act) requirements.

4 Mar 2021

Administering zinc supplements to Covid-19 patients may help reduce mortality and recovery time

Administering zinc supplements to Covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time.

4 Mar 2021

Study shows potential benefits of green tea extracts in Down syndrome

A new study led by Belgian and Spanish researchers published in Scientific Reports adds evidence about the potential benefits of green tea extracts in Down syndrome.

3 Mar 2021

Combination of therapies may benefit patients with mitochondrial respiratory chain disorders

Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders.

3 Mar 2021

Placebo-like effects may explain the benefits of psychedelic drugs

Positive psychological effects associated with taking small doses of psychedelic drugs are likely the result of users' expectations, suggests a study published today in eLife.

3 Mar 2021

FDA clears new robotically-assisted surgical device for transvaginal hysterectomy

The U.S. Food and Drug Administration has authorized marketing of the Hominis Surgical System, a new robotically-assisted surgical device (RASD) that can help facilitate transvaginal hysterectomy in certain patients.

1 Mar 2021

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.

1 Mar 2021

FDA to finalize the issuance of emergency use authorization for vaccine distribution

Following today's positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

27 Feb 2021

FDA approves Nulibry to reduce risk of death caused by rare genetic, metabolic disorder

Today, the U.S. Food and Drug Administration approved Nulibry (fosdenopterin) for injection to reduce the risk of death due to Molybdenum Cofactor Deficiency Type A, a rare, genetic, metabolic disorder that typically presents in the first few days of life, causing intractable seizures, brain injury and death.

27 Feb 2021

Supplements News and Research

Triglyceride-lowering medication may lower stroke risk in people with heart disease

Probiotic supplements increase the diversity of intestinal bacteria in extremely preterm infants

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

Study describes the infection of human cells by intestinal pathogen during spaceflight

A sneak peek of the current state and future use of artificial intelligence in pathology

Despite modest progress, maternal and child undernutrition remains a key health concern

FDA authorizes first molecular non-prescription, at-home COVID-19 test

FDA issues emergency use authorization for T-Detect COVID Test

FDA plans to further reduce toxic elements in foods for babies and young children

Study: Grandmothers can play a key role in newborn care

FDA alerts consumers about improper use of thermal imaging systems, warns firms for marketing unapproved devices

Federal court order requires New York-based dietary supplement manufacturer to cease operations

Administering zinc supplements to Covid-19 patients may help reduce mortality and recovery time

Study shows potential benefits of green tea extracts in Down syndrome

Combination of therapies may benefit patients with mitochondrial respiratory chain disorders

Placebo-like effects may explain the benefits of psychedelic drugs

FDA clears new robotically-assisted surgical device for transvaginal hysterectomy

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

FDA to finalize the issuance of emergency use authorization for vaccine distribution

FDA approves Nulibry to reduce risk of death caused by rare genetic, metabolic disorder

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News